http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112342161-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b96e172664eb7eb9b14496ce3b8d9dbc
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6869
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-01
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-04
filingDate 2020-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2eecdca58b2a594b15b2125d6614c636
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccba5c70ffaf207113b6d376b79417a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a87cd8e27171cf507c95d13f5fbbd485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc477425507a68b774f4c7d246498347
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_118ca534555fb3fecb1aa456331dabad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_691780fc69ab3161ab7976602145c15f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4d578657b2593200fe30d11c1acc5c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9058a8f994888fd87265e7ab91723ad6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb6981dac839fc9577c6b7dd55e4f202
publicationDate 2021-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-112342161-A
titleOfInvention A screening method for the combination of intestinal flora used to characterize lung adenocarcinoma with Qi deficiency and phlegm-dampness syndrome, and a method for establishing the intestinal flora combination and model
abstract The invention discloses a screening method for the combination of intestinal flora for characterizing lung adenocarcinoma with qi deficiency and phlegm-dampness syndrome, and a method for establishing the intestinal flora combination and model. The gut microbes of the patients were sequenced, and it was found that the top 6 gut microbiota with the most abundant distribution at the genus level were Bacteroides, Faecalibacterium, Bacteroides, Megamonas, Bifidobacterium, Clostridium, and then used LEfSe analysis method to screen out 4 particularly significant genera Bacteroidetes, Parabacteroides dineri, Prevotella and Flavobacterium, and then used their relative abundance as the autogenous genera. A logistic regression model was established to characterize lung adenocarcinoma with Qi deficiency and phlegm-dampness syndrome, and the metagenomics results were used to verify the accuracy of the logistic regression model. The combination of intestinal flora was used for objective quantification. The goal of non-small cell lung cancer with Qi deficiency and phlegm dampness syndrome.
priorityDate 2020-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970

Total number of triples: 29.